易方达沪深300医药ETF(512010)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
667,797,589.63 |
-2,524,304,280.26 |
-4,203,044,887.38 |
-2,625,529,850.88 |
| 利息合计 |
97,918.50 |
3,155,263.80 |
2,859,180.04 |
11,548,944.01 |
| 其中：存款利息收入 |
97,918.50 |
440,325.93 |
226,002.39 |
608,246.15 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-503,365,873.41 |
-2,482,652,737.48 |
-1,379,027,844.99 |
-1,577,121,072.62 |
| 其中：股票投资收益 |
-698,877,787.16 |
-2,828,562,355.94 |
-1,561,918,178.20 |
-1,790,078,090.77 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
195,511,913.75 |
345,909,618.46 |
182,890,333.21 |
212,957,018.15 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
1,166,906,866.51 |
-68,398,315.56 |
-2,838,134,163.24 |
-1,094,958,772.48 |
| 其他收入 |
4,158,678.03 |
23,591,508.98 |
11,257,940.81 |
35,001,050.21 |
| 费用 |
67,124,364.42 |
119,748,534.51 |
56,175,828.43 |
114,090,550.45 |
| 管理人报酬 |
54,608,660.00 |
94,831,726.19 |
44,481,864.25 |
90,322,400.62 |
| 基金托管费 |
10,921,732.04 |
18,966,345.22 |
8,896,372.81 |
18,064,480.12 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
1,593,972.38 |
5,940,688.98 |
2,788,111.64 |
5,664,282.84 |
| 利润总额 |
600,673,225.21 |
-2,644,052,814.77 |
-4,259,220,715.81 |
-2,739,620,401.33 |
微信公众号
证券之星APP
基本资料
